Alcohol Use Disorder Associated Gene FNDC4 Alters Glutamatergic and GABAergic Neurogenesis.

Saved in:
Bibliographic Details
Title: Alcohol Use Disorder Associated Gene FNDC4 Alters Glutamatergic and GABAergic Neurogenesis.
Authors: Zhu X; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A., John AJ; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A., Wang L; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A., Kim S; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A., Ding E; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A., Saleh A; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A., Marín-Goñi I; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A., Jomaa A; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A., Gao H; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A., Wai CM; Department of Biochemistry and Molecular Genetics, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA., Moon I; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A., Coombes BJ; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, U.S.A., Kerr TM; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A., Suto N; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A., Wang L; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A., Frye MA; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, U.S.A., Biernacka JM; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, U.S.A.; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, U.S.A., Karpyak VM; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, U.S.A., Li H; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A., Weinshilboum RM; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A., Liu D; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN. U.S.A.
Source: BioRxiv : the preprint server for biology [bioRxiv] 2025 May 16. Date of Electronic Publication: 2025 May 16.
Publication Type: Journal Article; Preprint
Journal Info: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2692-8205
DOI:10.1101/2025.05.15.654319